Estrogen Receptor-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Estrogen Receptor-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk [Phase 4]
A Phase 4 clinical trial evaluating ovarian function suppression in premenopausal, node-positive, estrogen receptor-positive, HER2-negative …
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (NeoHunter) [Phase 2]
A Phase 2 trial evaluating neoadjuvant therapy for ER+/HER2- breast cancer comparing High-Intensity Focused Ultrasound (HIFU) plus toripalim…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer [Phase 2]
A Phase 2 neoadjuvant and adjuvant trial evaluating ribociclib with endocrine therapy for clinically high-risk ER-positive, HER2-negative br…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
A clinical trial update describing a study to identify primary resistance to CDK4/6 inhibitors in breast cancer.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
A clinical trial update from Aarhus University Hospital outlines early metabolic health changes observed in breast cancer patients starting …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating BYL719 (alpelisib) with letrozole in post-menopausal women with hormone receptor-positive metastatic breas…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients
Recruiting clinical study evaluating biophysical and mechanical properties of skin in patients with breast cancer, including estrogen recept…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC [Phase 2]
Phase 2 clinical trial evaluating a combination of immunotherapy, hormone therapy, and an AKT inhibitor for premenopausal, ER-positive metas…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer [Phase 2]
A Phase 2 study evaluating QL1706 in combination with chemotherapy as neoadjuvant therapy for early high-risk estrogen receptor-positive, HE…
-
CLINICAL_TRIALS research · 2018-04-13Clinical Trial Update: Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant letrozole in combination with chemotherapy for estrogen receptor-positive, HER2-negative breas…
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
This clinical trial update discusses the use of the Oncotype DX genomic test in estrogen receptor-positive, HER2-negative breast cancer with…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients
An observational study evaluating how patients with estrogen receptor-positive breast cancer respond to tamoxifen.